Warfarin pharmacogenetic trials: Is there a future for pharmacogenetic- guided dosing?

Stuart A. Scott, Steven A. Lubitz

Research output: Contribution to journalReview articlepeer-review

21 Scopus citations
Original languageEnglish
Pages (from-to)719-722
Number of pages4
JournalPharmacogenomics
Volume15
Issue number6
DOIs
StatePublished - Apr 2014

Keywords

  • CYP2C9
  • VKORC1
  • clinical utility
  • pharmacogenetics
  • pharmacogenomics
  • randomized controlled clinical trial
  • warfarin

Cite this